Modified form of the fibrinogen Bβ chain (des-Gln Bβ), a potential long-lived marker of pancreatitis

Clinical Chemistry

Volumn 53, Issue 12, 2007, Pages 2105-2111

  Schmidt, David ^a   Brennan, Stephen O ^a  

^a CANTERBURY HEALTH LABORATORIES   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLASE; BBETA FIBRINOGEN; BIOLOGICAL MARKER; CARBOXYPEPTIDASE A; FIBRINOGEN; ISOPROTEIN;

ACUTE DISEASE; ARTICLE; BLOOD; ELECTROSPRAY MASS SPECTROMETRY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; METABOLISM; PANCREATITIS;

ACUTE DISEASE; AMYLASES; BIOLOGICAL MARKERS; CARBOXYPEPTIDASES A; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FIBRINOGEN; HUMANS; PANCREATITIS; PROTEIN ISOFORMS; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION;

EID: 55849124110     PISSN: 00099147     EISSN: 15308561     Source Type: Journal    
DOI: 10.1373/clinchem.2007.093179     Document Type: Article

References (21)

1. Henschen A, McDonagh J. Fibrinogen, fibrin and factor XIII. In: Zwaal FFA, Hemker HC, eds. Blood Coagulation. Amsterdam: Elsevier Science Publishers BV, 1986;171-241.
2. Doolittle RF. The molecular biology of fibrin. In:. Stamatoyannopoulos G, Nienhuis AW, Majerus PW, Varmus H, eds. The Molecular Basis of Blood Diseases. Philadelphia: WB Saunders Company, 1994;701-23.
3. Mosesson MW, Sibenlist KR, Mah DA. The structure and biological features of fibrinogen and fibrin. Ann NY Acad Sci 2001;936:11-30. (Pubitemid 32613890)
4. Cote HC, Lord ST, Pratt KP. γ-Chain dysfibrinogenemias: molecular structure-function relationships of naturally occurring mutations in the gamma chain of human fibrinogen. Blood 1998;92:2195-212. (Pubitemid 28452959)
5. Brennan SO. Electrospray ionisation analysis of human fibrinogen. Thromb Haemost 1997;78:1055-8. (Pubitemid 27417300)
6. Brennan SO, Fellowes AP, Faed JL, George PM. Hypofibrinogenemia in an individual with two coding (γ82 A→G and Bβ235 P→L) and two non-coding mutations. Blood 2000;95:1709-13. (Pubitemid 30120833)
7. Brennan SO, Hammonds B, George PM. Aberrant hepatic processing causes removal of activation peptide and primary polymerization site from fibrinogen Canterbury (Aα20 Val→Asp). J Clin Invest 1995;96:2854-8.
8. Liew OW, Chong JPC, Yandle TG, Brennan SO. Preparation of recombinant thioredoxin fused N-terminal proCNP: analysis of enterokinase cleavage products reveals new enterokinase cleavage sites. Protein Expr Purif 2005;41:332-40. (Pubitemid 40607779)
9. Brennan SO, Fellows AP, George PM. Albumin Banks Peninsula: a new termination variant characterised by electrospray mass spectrometry. Biochim Biophys Acta 1999;1433:321-6. (Pubitemid 29369066)
10. Maghzal GJ, Brennan SO, George PM. Fibrinogen Bβ polymorphisms do not directly contribute to an altered in vitro clot structure in humans. Thromb and Haemost 2003;90:1021-8. (Pubitemid 38004419)
11. Brennan SO, George PM. Three truncated forms of serum albumin associated with pancreatic pseudocyst. Biochim Biophys Acta 2000;1481:337-43.
12. Stewart JD, Gilvarg C. Determination of the activity of carboxypeptidase A in the blood of healthy human adults. Clin Chim Acta 1999;281:19-28. (Pubitemid 29142311)
13. Roth M, Rohner A. Determination of pancreatic carboxypeptidase A in human blood serum. Clin Chim Acta 1983;135:65-71. (Pubitemid 14241239)
14. Kazmierczak SC, Van Lente F. Measuring carboxypeptidase A activity with a centrifugal analyzer: analytical and clinical considerations. Clin Chem 1989;35:251-5. (Pubitemid 19075601)
15. Peterson LM, Holmquist B, Bethune JL. A unique activity assay for carboxypeptidase A in human serum. Anal Biochem 1982;125:420-6. (Pubitemid 13219790)
16. Brown KS, Kingsbury WD, Hall NM, Dunn GL, Gilvarg C. Determination of carboxypeptidase A using N-acetyl-phenylalanyl-3-thiaphenylalanine as substrate: application to a direct serum assay. Anal Biochem 1987;161:219-25. (Pubitemid 17036710)
17. Petra PH, Hermodson MA, Walsh KA, Neurath H. Characterization of bovine carboxypeptidase A. Biochemistry 1971;10:4023-5.
18. Pascual R, Burgos FJ, Salva M, Soriano F, Mendez E, Avilés FX. Purification and properties of five different forms of human procarboxypeptidases. Eur J Biochem 1989;179:609-16. (Pubitemid 19062337)
19. Gardell SJ, Craik CS, Clauser E, Goldsmith EJ, Stewart CB, Graf M, et al. A novel rat carboxypeptidase, CPA2: characterization, molecular cloning, and evolutionary implications on substrate specificity in the carboxypeptidase gene family. J Biol Chem 1988;263:17828-36.
20. Reznik SE, Fricker LD. Carboxypeptidases from A to Z: implications in embryonic development and Wnt binding. Cell Mol Life Sci 2001;58:1790-804. (Pubitemid 33108770)
21. Ton GN, Weichert JP, Longino MA, Fine JP, Kwon GS. Methoxypoly-(ethylene glycol)-conjugated carboxypeptidase A for solid tumor targeting: part II: pharmacokinetics and biodistribution in normal and tumor-bearing rodents. J Control Release 2005;104:155-66. (Pubitemid 40615243)